Utilising biosensor-based approaches for identifying neurotropic viruses

Rev Med Virol. 2024 Jan;34(1):e2513. doi: 10.1002/rmv.2513.

Abstract

Neurotropic viruses, with their ability to invade the central nervous system, present a significant public health challenge, causing a spectrum of neurological diseases. Clinical manifestations of neurotropic viral infections vary widely, from mild to life-threatening conditions, such as HSV-induced encephalitis or poliovirus-induced poliomyelitis. Traditional diagnostic methods, including polymerase chain reaction, serological assays, and imaging techniques, though valuable, have limitations. To address these challenges, biosensor-based methods have emerged as a promising approach. These methods offer advantages such as rapid results, high sensitivity, specificity, and potential for point-of-care applications. By targeting specific biomarkers or genetic material, biosensors utilise technologies like surface plasmon resonance and microarrays, providing a direct and efficient means of diagnosing neurotropic infections. This review explores the evolving landscape of biosensor-based methods, highlighting their potential to enhance the diagnostic toolkit for neurotropic viruses.

Keywords: biosensors; central nervous system; diagnostic methods; neurotropic viruses; virus detection.

Publication types

  • Review

MeSH terms

  • Biosensing Techniques*
  • Humans
  • Nervous System Diseases*
  • Poliomyelitis*
  • Viruses* / genetics